Published on 02/12/2025

Sealer/Crimper Calibration & Metrology: A Comprehensive Guide

The pharmaceutical industry relies heavily on various technologies to ensure the safety and efficacy of drug products. One critical aspect of this process is the calibration and metrology of sealing and crimping equipment used in the packaging of pharmaceuticals. This guide outlines the step-by-step process of sealer/crimper calibration and metrology, focusing on extractables and leachables (E&L) testing, analytical evaluation thresholds (AET), dose-based thresholds (DBT), and container closure integrity (CCI) within the context of single-use systems validation.

Understanding Seal Integrity and Its Importance

Seals play a vital role in maintaining the integrity of drug products, preventing contamination, and ensuring the stability of formulations throughout their shelf life. The effectiveness of these seals is paramount, especially for products that are sensitive to environmental conditions such as moisture, light, or particulate contamination. Sealer and crimper calibration ensures that these seals meet the regulatory requirements established by governing bodies such as the FDA, the EMA, and the MHRA.

Container closure systems (CCS) are indispensable in preserving pharmaceutical products against extractables and leachables (E&L). The presence of E&L can significantly impact product safety, leading to potential health implications for patients as well as regulatory scrutiny. Thus, establishing a robust calibration and metrology program is essential for pharmaceutical manufacturers.

Step 1: Establish Calibration Protocols

Before delving into the specifics of calibration, pharmaceutical organizations must first establish clear protocols that define the calibration frequency, responsibilities, and documentation requirements. These protocols should reflect both internal policies as well as applicable regulatory guidelines (e.g., USP General Chapter USP 1211 on CCI).

• Frequency: Establish calibration intervals based on equipment manufacturer recommendations and usage frequency.
• Responsibilities: Designate qualified personnel responsible for calibration and ensure they are trained appropriately.
• Documentation: Maintain thorough records of calibration processes and outcomes in compliance with good manufacturing practices (GMP).

Step 2: Selection of Calibration Equipment

Choosing the right calibration equipment is critical for achieving accurate measurements. Depending on the specific parameters to be calibrated, various types of measurement devices may be required, including:

• Force gauges for measuring seal strength.
• Temperature and humidity loggers to monitor environmental conditions during sealing.
• Digital calipers to assess the dimensions of crimp seals.

All calibration devices should themselves be calibrated against traceable standards to ensure their accuracy. Furthermore, equipment must meet requirements specified by relevant guidelines, such as the EU GMP Annex 1 and the PQRI guidelines.

Step 3: Executing Seal Calibration

The execution of seal calibration involves conducting a series of tests to validate the performance of the sealer or crimper. Each test should align with the criteria established in the protocols. Example tests might include:

• Seal Strength Testing: Utilize a force gauge to measure the strength of seals under controlled conditions, ensuring they meet the minimum strength requirement.
• Visual Inspection: Evaluate seals for any visible defects, such as incomplete sealing or foreign particulate presence.
• Dimensional Homogeneity: Use calipers to assess the dimensions of seals to confirm they fall within predetermined specifications.

It is essential to record all measurements and any anomalies encountered during testing. This documentation serves as critical evidence in the event of regulatory inspections or audits.

Step 4: Implementing E&L Testing and Risk Assessment

Extractables and leachables studies are fundamental to assessing the compatibility of container closure systems with drug products. Consequently, a thorough E&L risk assessment must be incorporated into the validation process. Start by identifying possible interactions between the primary drug product and the packaging components.

In the risk assessment, consider the following key parameters:

• The Material of Construction: Determine the types of materials used in containers and closures.
• Time and Temperature Conditions: Evaluate how time and temperature affect the potential for extractables and leachables.
• Targeted Compounds: Identify which substances require evaluation based on their potential impact on product stability and safety.

With the analytical evaluation threshold (AET) and dose-based threshold (DBT) criteria, organizations can define acceptable limits for E&L in their products, ensuring compliance with relevant regulations. Furthermore, the methodology should comply with the guidelines outlined in documents such as the PQRI guideline for E&L testing.

Step 5: Guaranteeing Container Closure Integrity

Container closure integrity (CCI) testing is crucial following the sealing process. This step verifies that the seals function as intended and remain secure under specified conditions. Common methods for conducting CCI tests include:

• Vacuum Decay Test: Measures the change in pressure within a sealed container to detect leaks.
• Helium Leak Test: Uses helium gas to assess the integrity of seals with high sensitivity, detecting small leaks that vacuum tests might miss.
• Bubble Leak Test: Involves submerging the sealed container in water to detect escaping bubbles from any leaks.

Testing to ensure proper CCI is necessary for compliance with USP standards, making it a critical part of the calibration and metrology process. Properly executed testing not only meets regulatory standards but also assures product safety for the end user.

Step 6: Documentation and Record Keeping

The final step in the calibration and metrology process is the thorough documentation of all activities. In the pharmaceutical industry, record keeping serves several purposes:

• Regulatory Compliance: Ensures compliance with various regulatory requirements, avoiding potential legal complications.
• Quality Assurance: Assures that the calibration and sealing processes are consistently followed and improved upon.
• Audit Readiness: Provides necessary documentation for audits and inspections, demonstrating adherence to good practices.

Every test result, calibration outcome, and E&L risk assessment should be documented clearly and stored securely. This not only protects the organization but also builds confidence in the integrity of the product.

Conclusion: Continuous Improvement in Calibration Practices

Calibration and metrology of sealers and crimpers in pharmaceutical packaging are critical to ensuring product safety, efficacy, and compliance with regulations. This comprehensive guide has provided a detailed step-by-step process for establishing effective calibration protocols, conducting thorough E&L risk assessments, and ensuring container closure integrity.

As technology advances, pharmaceutical organizations must continuously update their calibration practices in line with evolving regulatory expectations and technological innovations. By adhering to these guiding principles and maintaining a commitment to quality, organizations in the US, UK, and EU can uphold the integrity of their pharmaceutical products.